Patent · US Active

Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization

US7981939B2 · kind B2 · utility

4Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 2008
Grant dateJul 19, 2011
Priority date
Expiry dateDec 18, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Use of 2-bromo-isovanillin in the preparation of an anticancer medicament and/or radio- and chemotherapy sensitizing medicament is disclosed. The medicament for the treatment of cancers and/or for radio- and chemotherapy sensitization comprising 2-bromo-isovanillin as active ingredient provided herein has the following features: (1) low toxicity, without evident adverse effects; (2) significant therapeutic effect, with remarkable proliferation inhibiting and pro-apoptotic effects in tumor cells; (3) a broad-spectrum anticancer activity; (4) suitable to be used in combination with antimetabolites, to enhance the effects and meanwhile lower the toxicity, and also to reduce multi-drug resistance; (5) convenient and safe administration, the main route being oral.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.